Related Experiment Video
Updated: Apr 19, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Residence time and kinetic efficiency analysis of extracellular signal-regulated kinase 2 inhibitors
Darin Vanderpool1, Charles E Grimshaw1, J David Lawson2
1Enzymology and Biophysical Chemistry Group, Takeda California, San Diego, CA 92121, USA.
Abstract:
The RAS/RAF/MEK/ERK signal transduction cascade plays an important role in the regulation of critical cellular processes such as cell proliferation, migration, and differentiation. The up-regulation of this pathway can negatively affect cell homeostasis and is responsible for the development of various forms of cancer and inflammation processes. Therefore, there is a strong interest in pursuing drug programs targeting some of the enzymes involved in this pathway. In addition to the determination of Ki, Kd, IC50, and/or EC50, a more thorough kinetic analysis can provide useful information for the selection of the best lead series during the early stage of the drug discovery process. This study describes a medium-throughput fluorescent probe displacement assay for the rapid determination of the k(off) constant, residence time, and kinetic efficiency for ERK (extracellular signal-regulated kinase) inhibitors. Using this method, we have identified several inhibitors that we have subjected to further kinetic analysis by comparing k(off) constants determined for these time-dependent inhibitors using either the active or inactive form of ERK2.
Insights
This study introduces a new assay to rapidly measure the off-rate (k(off)) and residence time of ERK inhibitors, aiding drug discovery for cancer and inflammation by providing key kinetic data.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Discovery
- Cell Signaling and Cancer Research
Background:
- The RAS/RAF/MEK/ERK pathway regulates crucial cellular functions like proliferation, migration, and differentiation.
- Aberrant signaling in this pathway is implicated in cancer and inflammatory diseases.
- Targeting enzymes within this pathway is a key strategy in drug development.
Purpose of the Study:
- To develop a medium-throughput assay for rapid kinetic analysis of ERK inhibitors.
- To determine the k(off) constant, residence time, and kinetic efficiency of inhibitors.
- To provide enhanced data for selecting optimal lead compounds in early drug discovery.
Main Methods:
- Development of a fluorescent probe displacement assay for medium-throughput screening.
- Rapid determination of the dissociation rate constant (k(off)) for ERK inhibitors.
- Comparative kinetic analysis of inhibitors using active and inactive forms of ERK2.
Main Results:
- Successfully established a fluorescent probe displacement assay for kinetic profiling.
- Identified several ERK inhibitors with determined k(off) values and residence times.
- Demonstrated the utility of the assay in distinguishing inhibitor kinetics.
Conclusions:
- The developed assay provides a rapid and efficient method for kinetic characterization of ERK inhibitors.
- Kinetic parameters like k(off) and residence time are crucial for lead optimization.
- This approach facilitates informed selection of drug candidates targeting the ERK pathway.
More Related Videos
09:58An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence
Published on: May 2, 2025
07:12Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
Related Concept Videos
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases